Christopher Kosman

Christopher Kosman has a diverse work experience in the field of pharmacology and toxicology. Christopher started their career at Merck as a Scientist in 1999 and worked there until 2003. Christopher then joined Encysive Pharmaceuticals as a Principal Scientist III in drug development from 2004 to 2006. After that, Christopher founded their own company, Safety Pharmacology Consulting, LLC, in 2008, where they worked as a Founder and consultant until 2015. In 2007, they briefly worked as a Study Director at Ricerca Bioscience. From 2016 to 2018, Christopher worked as a Safety Pharmacologist at Sinclair Research Center, LLC. Currently, they hold the position of V.P. Pharmacology and Toxicology at Envol Biomedical since 2019.

Christopher Kosman has a Master of Science (MS) degree in toxicology from Thomas Jefferson University. Furthermore, they have pursued a field of study in regulatory pharmacology at the University of California, San Diego - School of Medicine. Additionally, Christopher holds a Doctor of Veterinary Medicine (DVM) degree in veterinary medicine from the University of Life Science.